Skip to main content

Find Clinical Trials

Home
Conditions
Immunoproliferative Disorders

Clinical trial condition

Immunoproliferative Disorders

Explore clinical trials studying Immunoproliferative Disorders. Study availability and eligibility vary by location and protocol.

10,013 public trials 2,032 recruiting studies

Refine in advanced search Browse all conditions

Immunoproliferative Disorders trial results

Suspended

Molecular Basis of Langerhans and Non-Langerhans Cell Histiocytic Neoplasms and Castleman Disease

NCT05028621

Conditions: Castleman Disease, Castleman's Disease (CD), Hemic and Lymphatic Diseases, +12 more
Locations: Cleveland Clinic, Case Comprehensive Cancer Center Cleveland, Ohio, United States

View Trial Details

Suspended

Pembrolizumab in Neoplasms or Lymphomas

NCT03316573

Conditions: Dendritic Cell Sarcoma, Follicular, Dendritic Cell Sarcoma, Interdigitating, Follicular Dendritic Cell Sarcoma, +12 more
Locations: Northwestern University Chicago, Illinois, United States

Massachusetts General Hospital Boston, Massachusetts, United States

Dana Farber Cancer Institute Boston, Massachusetts, United States

University of Nebraska Omaha, Nebraska, United States

View Trial Details

Withdrawn

Pre-emptive Anakinra for Cytokine Event Reduction

NCT06703216

Conditions: B-Acute Lymphoblastic Leukemia, Burkitt Lymphoma, CAR-T Cell Therapy, +24 more
Locations: Ann & Robert H. Lurie Children's Hospital of Chicago Chicago, Illinois, United States

View Trial Details